狼疮影响追踪量表在五个欧洲临床实践环境中的跨文化验证
本研究在五个欧洲国家的临床环境中前瞻性、观察性、横断面、多中心验证狼疮影响追踪量表(LIT)的跨文化效度、可接受性和可行性。结果显示LIT在不同国家间文化差异项目功能可忽略,与SF-36多个维度及医生评估指标相关,Cronbach α为0.89-0.92,患者和医生接受度良好。结论认为LIT在五个欧洲国家得到验证,可用于常规临床实践评估患者报告结局。
要点
- LIT在五个欧洲国家间文化差异项目功能可忽略(伪R²差异0.01-0.04)。
- LIT与SF-36躯体功能、社会角色功能、活力、躯体疼痛和心理健康强相关(P<0.001)。
- LIT在各国Cronbach α为0.89-0.92,患者和医生接受度良好。
核心结论
- LIT在五个参与的欧洲国家得到验证,具有可靠性和跨文化不变性。
- LIT可用于常规临床实践评估和随访患者报告结局,以改善医患互动。
研究设计与样本
- 前瞻性、观察性、横断面、多中心验证研究,在临床环境中开展。
- 患者就诊前完成LIT、SF-36和护理满意度问卷;就诊时医生评估疾病活动度(SELENA-SLEDAI)、器官损害(SDI)和 flare 发生。
- 采用差异项目功能(Differential Item Functioning)方法评估跨文化效度。
主要发现
- 18.3%的患者经历 flare;平均SELENA-SLEDAI评分3.4(4.5);平均SDI评分0.8(1.4)。
- SF-36平均躯体成分总结评分42.8(10.8),心理成分总结评分43.0(12.3)。
- 平均LIT评分34.2(22.3)(中位数32.5),提示狼疮对患者日常生活有中度影响。
- 跨国家文化差异项目功能可忽略(伪R²差异0.01-0.04)。
- LIT评分与医生整体评估、SELENA-SLEDAI、SDI=0(P<0.035)及无 flare(P=0.004)之间存在差异。
关键数值与推荐
- 跨文化效度:伪R²差异0.01-0.04,文化差异项目功能可忽略。
- 内部一致性:Cronbach α系数在各国为0.89-0.92。
- LIT与SELENA-SLEDAI、SDI=0(P<0.035)及无 flare(P=0.004)相关。
- LIT与SF-36躯体功能、社会角色功能、活力、躯体疼痛和心理健康相关(P<0.001)。
临床怎么用
- LIT可在常规临床实践中用于评估和随访SLE患者的患者报告结局。
- 使用LIT有助于改善医患互动。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: The aim was to evaluate the cross-cultural validity of the Lupus Impact Tracker (LIT) in five European countries and to assess its acceptability and feasibility from the patient and physician perspectives. METHODS: A prospective, observational, cross-sectional and multicentre validation study was conducted in clinical settings. Before the visit, patients completed LIT, Short Form 36 (SF-36) and care satisfaction questionnaires. During the visit, physicians assessed disease activity [Safety of Estrogens in Lupus Erythematosus National Assessment (SELENA)-SLEDAI], organ damage [SLICC/ACR damage index (SDI)] and flare occurrence. Cross-cultural validity was assessed using the Differential Item Functioning method. RESULTS: Five hundred and sixty-nine SLE patients were included by 25 specialists; 91.7% were outpatients and 89.9% female, with mean age 43.5 (13.0) years. Disease profile was as follows: 18.3% experienced flares; mean SELENA-SLEDAI score 3.4 (4.5); mean SDI score 0.8 (1.4); and SF-36 mean physical and mental component summary scores: physical component summary 42.8 (10.8) and mental component summary 43.0 (12.3). Mean LIT score was 34.2 (22.3) (median: 32.5), indicating that lupus moderately impacted patients' daily life. A cultural Differential Item Functioning of negligible magnitude was detected across countries (pseudo- R 2 difference of 0.01-0.04). Differences were observed between LIT scores and Physician Global Assessment, SELENA-SLEDAI, SDI scores = 0 (P < 0.035) and absence of flares (P = 0.004). The LIT showed a strong association with SF-36 physical and social role functioning, vitality, bodily pain and mental health (P < 0.001). The LIT was well accepted by patients and physicians. It was reliable, with Cronbach α coefficients ranging from 0.89 to 0.92 among countries. CONCLUSION: The LIT is validated in the five participating European countries. The results show its reliability and cultural invariability across countries. They suggest that LIT can be used in routine clinical practice to evaluate and follow patient-reported outcomes in order to improve patient-physician interaction.
引用
- Schneider M, Mosca M, Pego-Reigosa JM, et al. Cross-cultural validation of Lupus Impact Tracker in five European clinical practice settings. Rheumatology (Oxford). 2017. PMID: 28204765. doi:10.1093/rheumatology/kew492
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。